BB Biotech AG's Form 4 filing
Black Diamond Therapeutics, Inc. (BDTX) · filed Mar 20, 2025
- Accession no.
- 0001104659-25-026305
- Filed
- Mar 20, 2025, 9:01 PM ET
- Trade date
- Mar 19, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions. Open-market sales total $12.0M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BB Biotech AGCIK 0000924223 | 10% Owner |
| Biotech Growth N VCIK 0001259869 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | Common Stock | SSaleDisposed | −1,000,000 | $2.07 | −$2,069,100 | 7,517,839 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −300,000 | $1.94 | −$582,900 | 7,217,839 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −1,000,000 | $2.31 | −$2,308,100 | 6,217,839 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −2,000,000 | $2.00 | −$4,000,800 | 4,217,839 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −400,000 | $2.09 | −$837,160 | 3,817,839 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −584,292 | $1.95 | −$1,141,239.13 | 3,233,547 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −500,000 | $2.12 | −$1,058,450 | 2,733,547 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.